Tech Company Financing Transactions
Tango Therapeutics Funding Round
On 8/19/2020, Tango Therapeutics raised $50 million in funding from Casdin Capital, Boxer Capital and Cormorant Asset Management.
Transaction Overview
Company Name
Announced On
8/19/2020
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company will use the funding to initiate clinical studies of its lead program in the next 18 months and drive progress for other wholly owned programs in late-stage drug discovery.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 Binney St. 700
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of targeted therapies to people with cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at driver genes in cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Barbara Weber
Chief Financial Officer
Daniella Beckman
Chief Scientific Officer
Alan Huang
Browse more venture capital transactions:
Prev: 8/19/2020: SpaceX venture capital transaction
Next: 8/19/2020: SpyCloud venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs